These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30259768)

  • 21. Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques.
    Ning X; Sun J; Han X; Wu Y; Yan Z; Han J; He Z
    Drug Dev Ind Pharm; 2011 Jun; 37(6):727-36. PubMed ID: 21204747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of pH Modulation on Dynamic Behavior of Gel Layer and Release of Weakly Basic Drug from HPMC/Wax Matrices, Controlled by Acidic Modifiers Evaluated by Multivariate Data Analysis.
    Mašková E; Kubová K; Vysloužil J; Pavloková S; Vetchý D
    AAPS PharmSciTech; 2017 May; 18(4):1242-1253. PubMed ID: 27474035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.
    Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
    Hasçiçek C; Yüksel-Tilkan G; Türkmen B; Ozdemir N
    Acta Pharm; 2011 Sep; 61(3):303-12. PubMed ID: 21945909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple and effective method to improve bioavailability of glimepiride by utilizing hydrotropy technique.
    Li H; Ma L; Li X; Cui X; Yang W; Shen S; Chen M
    Eur J Pharm Sci; 2015 Sep; 77():154-60. PubMed ID: 26093052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique.
    Li H; Pan T; Cui Y; Li X; Gao J; Yang W; Shen S
    Int J Nanomedicine; 2016; 11():3777-88. PubMed ID: 27540291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix tablets for sustained release of repaglinide: Preparation, pharmacokinetics and hypoglycemic activity in beagle dogs.
    He W; Wu M; Huang S; Yin L
    Int J Pharm; 2015 Jan; 478(1):297-307. PubMed ID: 25434592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carboxymethyl fenugreek galactomannan-gellan gum-calcium silicate composite beads for glimepiride delivery.
    Bera H; Mothe S; Maiti S; Vanga S
    Int J Biol Macromol; 2018 Feb; 107(Pt A):604-614. PubMed ID: 28916379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronotherapeutic drug delivery of Tamarind gum, Chitosan and Okra gum controlled release colon targeted directly compressed Propranolol HCl matrix tablets and in-vitro evaluation.
    Newton AM; Indana VL; Kumar J
    Int J Biol Macromol; 2015 Aug; 79():290-9. PubMed ID: 25936283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Swelling kinetics of spray-dried chitosan acetate assessed by magnetic resonance imaging and their relation to drug release kinetics of chitosan matrix tablets.
    Huanbutta K; Sriamornsak P; Limmatvapirat S; Luangtana-anan M; Yoshihashi Y; Yonemochi E; Terada K; Nunthanid J
    Eur J Pharm Biopharm; 2011 Feb; 77(2):320-6. PubMed ID: 21129484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elucidation of release characteristics of highly soluble drug trimetazidine hydrochloride from chitosan-carrageenan matrix tablets.
    Li L; Wang L; Shao Y; Tian Y; Li C; Li Y; Mao S
    J Pharm Sci; 2013 Aug; 102(8):2644-54. PubMed ID: 23754467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moulded cross-linked chitosan matrix systems for controlled drug release.
    Tarirai C; Enslin GM; Steenekamp JH; Hamman JH
    Pharm Dev Technol; 2011 Aug; 16(4):295-301. PubMed ID: 20214415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between the viscoelastic properties of the gel layer of swollen HPMC matrix tablets and their in vitro drug release.
    Hamed R; Al Baraghthi T; Sunoqrot S
    Pharm Dev Technol; 2018 Nov; 23(9):838-848. PubMed ID: 27808590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chitosan-polycarbophil interpolyelectrolyte complex as a matrix former for controlled release of poorly water-soluble drugs I: in vitro evaluation.
    Lu Z; Chen W; Hamman JH
    Drug Dev Ind Pharm; 2010 May; 36(5):539-46. PubMed ID: 19877828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
    Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
    Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.
    Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T
    Drug Deliv; 2007 Nov; 14(8):507-15. PubMed ID: 18027180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan.
    El Maghraby GM; Elzayat EM; Alanazi FK
    Drug Dev Ind Pharm; 2012 Aug; 38(8):971-8. PubMed ID: 22092113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absolute bioavailability of glimepiride (Amaryl) after oral administration.
    Badian M; Korn A; Lehr KH; Malerczyk V; Waldhäusl W
    Drug Metabol Drug Interact; 1994; 11(4):331-9. PubMed ID: 12369756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.